Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to -$8000.0.

  • Incannex Healthcare's Capital Expenditures changed N/A to -$8000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $10000.0, marking a year-over-year change of. This contributed to the annual value of $8000.0 for FY2025, which is 9711.19% down from last year.
  • Incannex Healthcare's Capital Expenditures amounted to -$8000.0 in Q4 2025.
  • Over the past 5 years, Incannex Healthcare's Capital Expenditures peaked at $221000.0 during Q3 2023, and registered a low of -$8000.0 during Q4 2025.
  • Its 3-year average for Capital Expenditures is $41000.0, with a median of $3000.0 in 2024.
  • Within the past 5 years, the most significant YoY rise in Incannex Healthcare's Capital Expenditures was 36666.67% (2025), while the steepest drop was 36666.67% (2025).
  • Quarter analysis of 3 years shows Incannex Healthcare's Capital Expenditures stood at $59000.0 in 2023, then plummeted by 94.92% to $3000.0 in 2024, then plummeted by 366.67% to -$8000.0 in 2025.
  • Its last three reported values are -$8000.0 in Q4 2025, $2000.0 for Q3 2025, and $16000.0 during Q1 2025.